(Q44656299)

5 December 2017

title

Prolonged survival in acute myelogenous leukaemia without maintenance chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6200742

27 August 2023

1 reference

1 reference

1

R Champlin

1 reference

5 December 2017

R. Champlin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6200742

27 August 2023

A. Jacobs

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6200742

27 August 2023

R. P. Gale

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6200742

27 August 2023

R. Boccia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6200742

27 August 2023

R. Elashoff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6200742

27 August 2023

K. Foon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6200742

27 August 2023

J. Zighelboim

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6200742

27 August 2023

language of work or name

English

0 references

publication date

1 April 1984

1 reference

5 December 2017

21 April 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6200742

full work available at URL

27 August 2023

https://api.elsevier.com/content/article/PII:S0140673684913503?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)91350-3

https://api.elsevier.com/content/article/PII:S0140673684913503?httpAccept=text/plain

27 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)91350-3

27 August 2023

1 reference

5 December 2017

volume

1

1 reference

5 December 2017

issue

8382

1 reference

5 December 2017

page(s)

894-896

1 reference

High remission-induction rate in acute myeloid leukaemia

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991350-3

7 January 2021

Treatment of acute myeloid leukaemia with daunorubicin, cytosine arabinoside, mercaptopurine, L-asparaginase, prednisone and thioguanine: results of treatment with five multiple-drug schedules. Report of the Medical Research Council's Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991350-3

7 January 2021

Therapy of acute myelogeneous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991350-3

7 January 2021

Intensive five-drug combination chemotherapy for adult acute non-lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991350-3

7 January 2021

Long survival in acute myelogenous leukaemia: an international collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991350-3

7 January 2021

Chemoimmunotherapy of adult acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991350-3

7 January 2021

Intensive chemotherapy for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991350-3

7 January 2021

High-dose combination chemotherapy for acute nonlymphoblastic leukemia in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991350-3

7 January 2021

Controversies in the therapy of acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991350-3

7 January 2021

The role of immunotherapy in acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991350-3

7 January 2021

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991350-3

7 January 2021

Treatment of acute myelogenous leukemia: influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991350-3

7 January 2021

Short-term treatment for acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991350-3

7 January 2021

Remission maintenance therapy in acute myelogenous leukemia

22

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)91350-3

27 August 2023

Identifiers

1 reference

5 December 2017

1 reference